4BIO Capital, founded in 2014, is a London-based venture fund specializing in Seed to Series D investments in BioTech, Healthcare, Life Science, and Medical Device sectors. With a portfolio of 13 companies and 5 successful exits, the fund is led by Partner Dmitry 'Dima' Kuzmin. One of their notable investments is Carisma Therapeutics. 4BIO Capital's focus is on nurturing early-stage advanced therapy companies, contributing to the growth of innovative startups in the healthcare industry. For more information, visit their website at www.4biocapital.com.